Pancreatic Cancer Research

ResearcherUniversity of Southern CaliforniaNo recent work listed

Syma Iqbal

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5010-5922; OpenAlex author ID A5067332117. Sources: ClinicalTrials.gov.

Their work

Papers
1
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 1 trial

Papers 1

  1. Dual blockade of epidermal growth factor receptor and insulin-like growth factor receptor-1 signaling in metastatic pancreatic cancer: phase Ib and randomized … Co-author DOI 10.1002/cncr.28744↗

Trials 1

  1. Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors Principal investigator NCT02259725↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Takeru Wakatsuki · 1 shared paper, 2014 · strength 0.04
  2. Charles David Blanke · 1 shared paper, 2014 · strength 0.04
  3. Heinz‐Josef Lenz · 1 shared paper, 2014 · strength 0.04
  4. Ramesh K. Ramanathan · 1 shared paper, 2014 · strength 0.04
  5. Andrew M. Lowy · 1 shared paper, 2014 · strength 0.04
  6. Philip A. Philip · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.